The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $15,529,693 Cooperative Agreement under the Minority Health and Health Disparities Research (CFDA 93.307) program to the University of Texas Rio Grande Valley (UTRGV). The grant will fund the establishment of the Rio Grande Valley Cancer Health Disparity Research Center (RGV-CHDRC) to develop a comprehensive biomedical research infrastructure and build capacity to reduce cancer and chronic disease disparities in...
The National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH), awarded a $403,313 Project Grant to Louisiana State University Health Sciences Center New Orleans (LSU Health Sciences Center New Orleans) to investigate the effectiveness of a multilevel integrated intervention for low-dose computed tomography (LDCT) lung cancer screening and smoking cessation among African Americans. The project, funded under the Minority Health and Health...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH), under the Minority Health and Health Disparities Research (CFDA 93.307) program, is providing $1,386,503 to the Morehouse School of Medicine to study racial disparities in lung cancer treatment and survival. The key objectives are to: 1) Determine racial disparities in receipt of cancer treatments, time to first treatment, number of...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), under the Minority Health and Health Disparities Research (CFDA 93.307) program, provides $331,944 to the University of California, Davis (UC Davis) to address cancer health disparities among American Indian and Alaskan Native (AIAN) communities. The key products and services to be delivered through this award include: Utilizing whole exome sequencing data from 300 Hispanic/Latino...
The National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH), awarded a $720,716 Project Grant under the Minority Health and Health Disparities Research (CFDA 93.307) program to Inovcares Connected Comprehensive Healthcare Corporation, a minority-owned small business. The award aims to evaluate the efficacy of Inovcares' culturally-sensitive telehealth platform in fostering community-based care coordination to address maternal mental...
The U.S. National Institute on Minority Health and Health Disparities (NIMHD) awarded a $513,169 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to the University of Texas Health Science Center at Houston (UTHealth). The purpose of this 5-year grant is to develop and pilot test a culturally appropriate, multilevel behavioral lifestyle intervention to improve physical activity, diet, weight loss, and liver-related outcomes for Hispanic/Latino patients...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) will provide $181,864 to the University of Pittsburgh to examine racial disparities in predictive modeling among survivors of critical illness. The research aims to identify and characterize racial differences in outcomes such as mortality, 90-day readmissions, and hospital-free days, as well as investigate potential bias within...
The National Cancer Institute (NCI) awarded a 5-year, $676,584 Project Grant under the Cancer Biology Research (CFDA 93.396) program to the University of Texas MD Anderson Cancer Center. The grant funds a research project titled "Decoding the Co-Evolution of Cancer Subclones and Their Ecosystem in TNBC Multi-Organ Metastasis." The project aims to expand the fundamental understanding of metastatic triple-negative breast cancer (MTNBC) by investigating the genomic and transcriptomic...
The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $329,048 Project Grant under the Minority Health and Health Disparities Research (CFDA 93.307) program to the University of Texas Health Science Center at Houston (UTHealth). The grant will fund a study to culturally adapt and pilot test the feasibility of a Behavioral Activation and Therapeutic Exposure for Grief (BATE-G) intervention for American Indian/Alaska Native (AI/AN) populations. Specifically, the...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $469,544 to The Ohio State University from July 1, 2024 to June 30, 2029. The research aims to unravel the role of the S100A7 protein and its impact on the tumor microenvironment in aggressive, treatment-resistant triple-negative breast cancer (TNBC), which disproportionately affects African American women. The project will leverage diverse TNBC...
The National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH), awarded a $1,058,750 Project Grant under the Minority Health and Health Disparities Research (CFDA 93.307) program to the University of South Alabama. The grant aims to examine the role of mitochondrial DNA (mtDNA) alterations in triple-negative breast cancer (TNBC) racial disparities and develop a non-invasive biomarker test using extracellular vesicles (EVs). Specifically, the project will analyze a panel of 11 key mtDNA mutations in European American and African American TNBC patients to identify aggressive tumor signatures. It will then measure these mtDNA mutations in circulating EVs to enable early detection of invasive lesions, predict metastatic recurrence, and monitor treatment response. This research could lead to the development of clinical assays to detect disparate tumor-specific mtDNA mutations and measure mtDNA content in EVs, improving early diagnosis, recurrence prediction, and treatment planning for racially diverse TNBC populations.